凯美拉治疗 KYMR
$131.73 +$3.61 (+2.82%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $131.07 -0.50%
开盘$129.41
昨收$128.12
当日区间$126.65 – $132.68
成交量787.0K
市值$11.25B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q3, ended Sep 2026
营收$0.00-100.0% YoY
营业利润-$147.23M-66.1% YoY
净利润-$132.00M-60.6% YoY
摊薄每股收益-$1.32-40.4% YoY
自由现金流-$78.23M-186.6% YoY
经营现金流-$77.91M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率-396.0%
净利率-341.8%
净资产收益率-27.3%
资产收益率-24.4%
投入资本回报率-29.8%
流动比率11.13
负债/资产比率8.6%
现金及投资$971.21M
总负债$63.02M
净现金（净负债）$908.20M
利润表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 报告营业总收入 | $0.00 | $65.00M | $34.37M | $39.21M | $2.87M |
| 营业总收入 | $0.00 | $65.00M | $34.37M | $39.21M | $2.87M |
| 营业费用 | $147.23M | $140.61M | $118.52M | $384.76M | $100.77M |
| 销售及管理费用 | $18.72M | $21.13M | $20.36M | $68.19M | $16.94M |
| -管理费用 | $18.72M | $21.13M | $20.36M | $68.19M | $16.94M |
| 研发费用 | $128.51M | $119.48M | $98.16M | $316.57M | $83.83M |
| 营业利润 | -$147.23M | -$75.61M | -$84.15M | -$345.54M | -$97.90M |
| 非经营性利息净收入（支出） | $15.23M | $14.40M | $14.92M | $38.05M | $10.92M |
| 非经营性利息收入 | $15.30M | $14.48M | $14.98M | $38.42M | $11.01M |
| 非经营性利息支出 | $62,000.00 | $81,000.00 | $61,000.00 | $370,000.00 | $90,000.00 |
| 特殊收益（费用） | $0.00 | – | – | -$3.86M | $0.00 |
| -减：资本性资产减值 | $0.00 | – | – | $3.86M | $0.00 |
| 税前利润 | -$132.00M | -$61.21M | -$69.23M | -$311.35M | -$86.98M |
| 净利润 | -$132.00M | -$61.21M | -$69.23M | -$311.35M | -$86.98M |
| 持续经营利润 | -$132.00M | -$61.21M | -$69.23M | -$311.35M | -$86.98M |
| 归属母公司净利润 | -$132.00M | -$61.21M | -$69.23M | -$311.35M | -$86.98M |
| 归属普通股股东净利润 | -$132.00M | -$61.21M | -$69.23M | -$311.35M | -$86.98M |
| 基本每股收益 | -$1.32 | -$0.62 | -$0.71 | -$3.69 | -$0.97 |
| 摊薄每股收益 | -$1.32 | -$0.62 | -$0.71 | -$3.69 | -$0.97 |
| 其他收入（支出） | – | – | – | -$3.86M | $0.00 |
资产负债表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 总资产 | $1.77B | $1.65B | $1.67B | $1.74B | $1.74B |
| 流动资产合计 | $998.59M | $737.27M | $677.43M | $871.21M | $871.21M |
| 现金及现金等价物与短期投资 | $971.21M | $690.99M | $650.93M | $848.28M | $848.28M |
| -现金及现金等价物 | $373.37M | $124.48M | $144.09M | $357.01M | $357.01M |
| -短期投资 | $597.84M | $566.51M | $506.84M | $491.27M | $491.27M |
| 其他流动资产 | $27.38M | $26.28M | $26.50M | $22.94M | $22.94M |
| 非流动资产合计 | $768.68M | $908.18M | $991.58M | $871.60M | $871.60M |
| 固定资产净值 | $78.69M | $81.07M | $83.35M | $85.53M | $85.53M |
| -固定资产原值 | $106.80M | $107.16M | $107.41M | $107.65M | $107.65M |
| -累计折旧 | -$28.11M | -$26.09M | -$24.06M | -$22.13M | -$22.13M |
| 投资及预付款 | $674.67M | $813.90M | $894.72M | $771.16M | $771.16M |
| -可供出售证券 | $674.67M | $813.90M | $894.72M | $771.16M | $771.16M |
| 其他非流动资产 | $15.32M | $13.21M | $13.51M | $14.91M | $14.91M |
| 负债合计 | $152.74M | $136.19M | $129.38M | $163.15M | $163.15M |
| 流动负债合计 | $89.72M | $71.33M | $62.64M | $83.21M | $83.21M |
| 应付款 | $11.92M | $8.92M | $12.84M | $4.02M | $4.02M |
| -应付账款 | $11.92M | $8.92M | $12.84M | $4.02M | $4.02M |
| 一年内应计费用 | $63.32M | $48.48M | $35.10M | $42.27M | $42.27M |
| 短期债务及融资租赁负债 | $13.58M | $13.70M | $13.73M | $13.76M | $13.76M |
| -一年内到期融资租赁负债 | $13.58M | $13.70M | $13.73M | $13.76M | $13.76M |
| 一年内递延负债 | $0.00 | $0.00 | $0.00 | $22.93M | $22.93M |
| 其他流动负债 | $905,000.00 | $236,000.00 | $976,000.00 | $242,000.00 | $242,000.00 |
| 非流动负债合计 | $63.02M | $64.86M | $66.74M | $79.94M | $79.94M |
| 长期债务及融资租赁负债 | $63.02M | $64.86M | $66.74M | $68.50M | $68.50M |
| -长期融资租赁负债 | $63.02M | $64.86M | $66.74M | $68.50M | $68.50M |
| 一年以上递延负债 | $0.00 | $0.00 | $0.00 | $11.44M | $11.44M |
| 股东权益合计 | $1.61B | $1.51B | $1.54B | $1.58B | $1.58B |
| 股东权益 | $1.61B | $1.51B | $1.54B | $1.58B | $1.58B |
| 股本 | $9,000.00 | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| -普通股 | $9,000.00 | $8,000.00 | $8,000.00 | $8,000.00 | $8,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.96B | $2.71B | $2.68B | $2.64B | $2.64B |
| 留存收益 | -$1.33B | -$1.20B | -$1.14B | -$1.07B | -$1.07B |
| 不影响留存收益的损益 | -$14.74M | -$7.16M | -$4.19M | $1.80M | $1.80M |
| 应收款 | – | $20.00M | – | – | – |
| -应收账款 | – | $20.00M | – | – | – |
现金流量表
| 项目 | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$77.91M | -$54.07M | -$88.84M | -$232.89M | -$66.75M |
| 持续经营经营活动现金流净额 | -$77.91M | -$54.07M | -$88.84M | -$232.89M | -$66.75M |
| 持续经营净利润 | -$132.00M | -$61.21M | -$69.23M | -$311.35M | -$86.98M |
| 折旧、折耗与摊销 | $2.02M | $2.03M | $2.02M | $8.31M | $2.03M |
| 营运资金变动 | $34.83M | -$11.50M | -$34.91M | $15.27M | $5.79M |
| -应收款变动 | $20.00M | -$20.00M | $0.00 | $947,000.00 | $0.00 |
| -预付资产变动 | -$1.10M | $223,000.00 | -$3.57M | -$2.36M | -$322,000.00 |
| -应付账款及应计费用变动 | $17.86M | $9.55M | $1.62M | $5.41M | $12.17M |
| -其他流动资产变动 | -$1.07M | $2.37M | $615,000.00 | $2.67M | $5.47M |
| -其他流动负债变动 | -$1.52M | -$1.48M | -$1.36M | -$5.04M | -$1.33M |
| -其他营运资金变动 | $654,000.00 | -$2.16M | -$32.21M | $13.64M | -$10.20M |
| 投资活动现金流净额 | $101.63M | $20.05M | -$142.84M | -$521.06M | -$394.40M |
| 持续经营投资活动现金流净额 | $101.63M | $20.05M | -$142.84M | -$521.06M | -$394.40M |
| 固定资产购置及出售净额 | -$315,000.00 | -$473,000.00 | -$434,000.00 | -$1.45M | -$106,000.00 |
| 投资购置及出售净额 | $101.95M | $20.52M | -$142.41M | -$519.61M | -$394.29M |
| 筹资活动现金流 | $225.57M | $14.42M | $18.77M | $990.71M | $705.22M |
| 持续经营筹资活动现金流净额 | $225.57M | $14.42M | $18.77M | $990.71M | $705.22M |
| 债务发行及偿还净额 | -$444,000.00 | -$436,000.00 | -$425,000.00 | -$1.49M | -$416,000.00 |
| 普通股发行净额 | $215.39M | – | – | $928.90M | $656.23M |
| 股票期权行使所得 | $10.62M | $14.86M | $19.19M | $63.31M | $49.41M |
| 期末现金余额 | $379.58M | $130.30M | $149.90M | $362.81M | $362.81M |
| 现金净变动 | $249.28M | -$19.60M | -$212.91M | $236.76M | $244.07M |
| 期初现金余额 | $130.30M | $149.90M | $362.81M | $126.05M | $118.74M |
| 自由现金流 | -$78.23M | -$54.54M | -$89.27M | -$234.34M | -$66.85M |
| 持续经营损益 | – | – | -$2.73M | – | – |
暂无评论——快来第一个聊聊 KYMR。
登录后参与讨论。